What's new
Fantasy Football - Footballguys Forums

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

My Stock Value Strategy Starts Now (1 Viewer)

David Dodds said:
so how many people still have HEB? (shares and price please)I have 9,000 @ 2.13 (I am kind of disappointed I did not manuever better when this thing crashed to $1.75, but it's hard because you start to suspect someone knows bad news.
Click to expand...
Holding 1,733 HEB @ average cost $1.83/m (bought 1,300 on 5/26 @ $1.48/m and then another 433 on 6/10 @ $2.87/m).Holding since 5/26 has felt more like a year than a month.Will not sell one share until FDA approval or denial. Go HEB! :shrug:
 
285 shares at an avg. of about $2.00. I dont feel like doing the math on my average exactly. I have bought and sold this thing so many times over the last 7 days. Figure I have 446 free trades left, might as well use them before they expire soon. I am going to be so spoiled when that is over with. I will just have to open a new one somewhere. If it drops again I will buy more.

 
i've been shorting HEB anytime it hits 2.25 or above. So far i've done well, although today i did lose some. Overall i'm up shorting this lemon though.

i always close my position be end of day so i don't risk getting caught if the 5% approval miracle happens.

i'm not going to enjoy watching all the lambs to slaughter on this one, but as long as they keep pumping it up it allows a better entry to short.

 
moderated said:
i've been shorting HEB anytime it hits 2.25 or above. So far i've done well, although today i did lose some. Overall i'm up shorting this lemon though.

i always close my position be end of day so i don't risk getting caught if the 5% approval miracle happens.

i'm not going to enjoy watching all the lambs to slaughter on this one, but as long as they keep pumping it up it allows a better entry to short.
Click to expand...
dropped from 20% to 5% in a couple days?
 
springroll said:
moderated said:
i've been shorting HEB anytime it hits 2.25 or above. So far i've done well, although today i did lose some. Overall i'm up shorting this lemon though.

i always close my position be end of day so i don't risk getting caught if the 5% approval miracle happens.

i'm not going to enjoy watching all the lambs to slaughter on this one, but as long as they keep pumping it up it allows a better entry to short.
Click to expand...
dropped from 20% to 5% in a couple days?
Click to expand...
No, i said the PPS represents a 20%ish shot for it to be approved. My personal opinion based on the research i've done puts it at about a 5% chance.i think the share price right now is over-inflated due to it being a "hot" stock among gambler and day traders. I don't think there is much sharp money in this stock, it's mainly gamblers who think they might get a huge return on their money.

 
Bought back 300 FAZ HEB @ roughly $2.50 and $3.75.....after selling 1000 for a 20 cent gain.

 
David Dodds said:
so how many people still have HEB? (shares and price please)I have 9,000 @ 2.13 (I am kind of disappointed I did not manuever better when this thing crashed to $1.75, but it's hard because you start to suspect someone knows bad news.
Click to expand...
970 total shares....400 at $1.49350 at $1.59220 at $2.02
 
holding 2000 shares @ 2.30. I sold for a little profit and then rebought the same day a couple weeks ago.

Also holding 2500 PRGN @ about a $4.00 average.

 
Been watching since Dodds started this thread, Vlad can no longer sit on the sidelines and watch. I opend a $3K Scottrade account today, the money should show up in the account tomorrow afternoon. Going to start with PRGN.

 
If you are long on HEB, you should listen to this interview:

Shareholder Meeting Attendee

I was following along with his comments on Thursday and was the primary reason I added 3,000 more shares. I am tempted to add more.

and for Moderated who believes this is a guy selling snake oil, please be careful. This could spike up very fast on approval or a Japan deal as an adjuvant.

Long and strong here. If this gets back to $2.00 I will definitely be adding shares.

 
David Dodds said:
If you are long on HEB, you should listen to this interview:

Shareholder Meeting Attendee

I was following along with his comments on Thursday and was the primary reason I added 3,000 more shares. I am tempted to add more.

and for Moderated who believes this is a guy selling snake oil, please be careful. This could spike up very fast on approval or a Japan deal as an adjuvant.

Long and strong here. If this gets back to $2.00 I will definitely be adding shares.
Click to expand...
The company chose not to webcast their SH meeting, but luckily there was a shareholder present to blog the meeting to the Yahoo finance board in real time, and later give an audio interview in which he is very positive about the company and which is posted to the web. This person demonstrated a fair amount of knowledge about the company, added comments about the FDA, and even passed along the company's "rebuttal" to Adam Feuerstein's articles... and their rebuttal is basically "Feuerstein's claims have no merit whatsoever and we won't give him any additional publicity by responding to them".Hemispherx has noticeably been talking about the flu adjuvant angle a lot recently... given the company's history of constantly finding new indications that Ampligen "looks promising" for, it's difficult for me not to believe this is yet another instance of Hemispherx having reached the end of the road for yet another indication (CFS in this case, if/when the FDA rejects their current New Drug Application), and moving on to their next target.

Feuerstein had the following comment about Hemispherx's claims about Ampligen's value as a H1N1 flu vaccine adjuvant:

Lately, Carter has been talking up his research "partners" in Japan and Italy who are desperate to work with Ampligen to develop new flu vaccines. Really? Where are the contracts? Why isn't there any definitive word from these partners about their Ampligen work? Where are the clinical trials?

 
Das Boot said:
The company chose not to webcast their SH meeting, but luckily there was a shareholder present to blog the meeting to the Yahoo finance board in real time, and later give an audio interview in which he is very positive about the company and which is posted to the web. This person demonstrated a fair amount of knowledge about the company, added comments about the FDA, and even passed along the company's "rebuttal" to Adam Feuerstein's articles... and their rebuttal is basically "Feuerstein's claims have no merit whatsoever and we won't give him any additional publicity by responding to them".

Hemispherx has noticeably been talking about the flu adjuvant angle a lot recently... given the company's history of constantly finding new indications that Ampligen "looks promising" for, it's difficult for me not to believe this is yet another instance of Hemispherx having reached the end of the road for yet another indication (CFS in this case, if/when the FDA rejects their current New Drug Application), and moving on to their next target.

Feuerstein had the following comment about Hemispherx's claims about Ampligen's value as a H1N1 flu vaccine adjuvant:

Lately, Carter has been talking up his research "partners" in Japan and Italy who are desperate to work with Ampligen to develop new flu vaccines. Really? Where are the contracts? Why isn't there any definitive word from these partners about their Ampligen work? Where are the clinical trials?
Click to expand...
Where are you reading this?
 
David Dodds said:
Das Boot said:
The company chose not to webcast their SH meeting, but luckily there was a shareholder present to blog the meeting to the Yahoo finance board in real time, and later give an audio interview in which he is very positive about the company and which is posted to the web. This person demonstrated a fair amount of knowledge about the company, added comments about the FDA, and even passed along the company's "rebuttal" to Adam Feuerstein's articles... and their rebuttal is basically "Feuerstein's claims have no merit whatsoever and we won't give him any additional publicity by responding to them".

Hemispherx has noticeably been talking about the flu adjuvant angle a lot recently... given the company's history of constantly finding new indications that Ampligen "looks promising" for, it's difficult for me not to believe this is yet another instance of Hemispherx having reached the end of the road for yet another indication (CFS in this case, if/when the FDA rejects their current New Drug Application), and moving on to their next target.

Feuerstein had the following comment about Hemispherx's claims about Ampligen's value as a H1N1 flu vaccine adjuvant:

Lately, Carter has been talking up his research "partners" in Japan and Italy who are desperate to work with Ampligen to develop new flu vaccines. Really? Where are the contracts? Why isn't there any definitive word from these partners about their Ampligen work? Where are the clinical trials?
Click to expand...
Where are you reading this?
Click to expand...
It's from this article.link

 
David Dodds said:
Das Boot said:
The company chose not to webcast their SH meeting, but luckily there was a shareholder present to blog the meeting to the Yahoo finance board in real time, and later give an audio interview in which he is very positive about the company and which is posted to the web. This person demonstrated a fair amount of knowledge about the company, added comments about the FDA, and even passed along the company's "rebuttal" to Adam Feuerstein's articles... and their rebuttal is basically "Feuerstein's claims have no merit whatsoever and we won't give him any additional publicity by responding to them".

Hemispherx has noticeably been talking about the flu adjuvant angle a lot recently... given the company's history of constantly finding new indications that Ampligen "looks promising" for, it's difficult for me not to believe this is yet another instance of Hemispherx having reached the end of the road for yet another indication (CFS in this case, if/when the FDA rejects their current New Drug Application), and moving on to their next target.

Feuerstein had the following comment about Hemispherx's claims about Ampligen's value as a H1N1 flu vaccine adjuvant:

Lately, Carter has been talking up his research "partners" in Japan and Italy who are desperate to work with Ampligen to develop new flu vaccines. Really? Where are the contracts? Why isn't there any definitive word from these partners about their Ampligen work? Where are the clinical trials?
Click to expand...
Where are you reading this?
Click to expand...
LOLI've never heard of a company not webcast, or at the very least allow you to phone in and listen to their shareholder meeting.

From what I've gathered from their shareholder meeting is about no one showed up.

Also, I can't imagine how a blog from a shareholder could hold any merit. Of course the guy is positive, he is a shareholder. The guy is knowledgeable about the company, sure, but I believe he works for a private jet company, so I can't imagine how he would have any idea to the merits of the drug, other then what he is being told.

again, I have no interest in HEB, so I'll cheer along from the sidelines, but take all of this with a grain of salt.

 
MechEng said:
David Dodds said:
Das Boot said:
The company chose not to webcast their SH meeting, but luckily there was a shareholder present to blog the meeting to the Yahoo finance board in real time, and later give an audio interview in which he is very positive about the company and which is posted to the web. This person demonstrated a fair amount of knowledge about the company, added comments about the FDA, and even passed along the company's "rebuttal" to Adam Feuerstein's articles... and their rebuttal is basically "Feuerstein's claims have no merit whatsoever and we won't give him any additional publicity by responding to them".

Hemispherx has noticeably been talking about the flu adjuvant angle a lot recently... given the company's history of constantly finding new indications that Ampligen "looks promising" for, it's difficult for me not to believe this is yet another instance of Hemispherx having reached the end of the road for yet another indication (CFS in this case, if/when the FDA rejects their current New Drug Application), and moving on to their next target.

Feuerstein had the following comment about Hemispherx's claims about Ampligen's value as a H1N1 flu vaccine adjuvant:

Lately, Carter has been talking up his research "partners" in Japan and Italy who are desperate to work with Ampligen to develop new flu vaccines. Really? Where are the contracts? Why isn't there any definitive word from these partners about their Ampligen work? Where are the clinical trials?
Click to expand...
Where are you reading this?
Click to expand...
It's from this article.link
Click to expand...
But don't you find it a bit suspicous that Ampligen was going to be a treatment for a number of afflictions and diseases and now it just happens to have value as a flu vaccine, only the latest and hottest disease in the news now? That coupled with the delay in approval and the vote to increase the share count will keep me away. Good luck though.
 
springroll said:
bunch of party poopers in here.
Click to expand...
I think the debate is good. I do not have nearly enough time to do all this research on my own, nor am I smart enough to understand it all. The bottom line is that there will always be differences in opinion with stocks...and opinions will be much stronger on anything that is more risky. Each person has to draw their own conclusions and only do what they are comfortable with....HEB owner
 
Last edited by a moderator:
Cromedog said:
springroll said:
bunch of party poopers in here.
Click to expand...
I think the debate is good. I do not have nearly enough time to do all this research on my own, nor am I smart enough to understand it all. The bottom line is that there will always be differences in opinion with stocks...and opinions will be much stronger on anything that is more risky. Each person has to draw their own conclusions and only do what they are comfortable with....HEB owner
Click to expand...
I like the debate too.
 
Cromedog said:
springroll said:
bunch of party poopers in here.
Click to expand...
I think the debate is good. I do not have nearly enough time to do all this research on my own, nor am I smart enough to understand it all. The bottom line is that there will always be differences in opinion with stocks...and opinions will be much stronger on anything that is more risky. Each person has to draw their own conclusions and only do what they are comfortable with....HEB owner
Click to expand...
I think it's a valid debate and I appreciate that everyone in this thread is good enough to educate those of us not really familiar with the market....but it's also akin to people talking about the odds and expected value in buying a ticket and winning the lottery....it's kind party pooperish. ...small HEB owner
 
David Dodds said:
Cromedog said:
springroll said:
bunch of party poopers in here.
Click to expand...
I think the debate is good. I do not have nearly enough time to do all this research on my own, nor am I smart enough to understand it all. The bottom line is that there will always be differences in opinion with stocks...and opinions will be much stronger on anything that is more risky. Each person has to draw their own conclusions and only do what they are comfortable with....HEB owner
Click to expand...
I like the debate too.
Click to expand...
no problems with debate. I just think on this particular stock we are past that point. I dont think anybody will be bailing out completely. Lots of FBGs stand to lose a lot of money or gain a lot of money. Being pretty much on the same team as a group will make that better either way.
 
David Dodds said:
Cromedog said:
springroll said:
bunch of party poopers in here.
Click to expand...
I think the debate is good. I do not have nearly enough time to do all this research on my own, nor am I smart enough to understand it all. The bottom line is that there will always be differences in opinion with stocks...and opinions will be much stronger on anything that is more risky. Each person has to draw their own conclusions and only do what they are comfortable with....HEB owner
Click to expand...
I like the debate too.
Click to expand...
I’ve chimed in numerous times on my HEB thoughts (long 1,733 shares) – will not repeat everything all over again. There is obvious concern with the history of Carter and Ampligen. However, regarding why I think Ampligen will be approved, I think it all boils down simply to this:- There is no current treatment for CFS- CFS is finally gaining respect as a real medical illness- Ampligen has been proven to work against CFS- Ampligen has been proven to be SAFE by the FDA – HEB submitted safety reports for YEARS and the FDA finally said no more, we trust you, do not send anymore safety reports, we’ve had our fill- IF CFS has no current drug, and Ampligen has been proven to work in named patient cases, and Ampligen is safe, what is the harm of Ampligen being approved for CFS? Even if CFS does not work on all patients, at least it could help some, who have NO OTHER ALTERNATIVE.- Why wouldn't the FDA approve based on the above?
 
Last edited by a moderator:
I think the challenge HEB faces is that CFS is not strictly defined. According to the wiki:

Chronic fatigue syndrome (CFS) is the most common name[1] given to an inadequately understood, variably debilitating disorder or disorders of uncertain causation. It is also commonly known as myalgic encephalomyelitis or ME.
Click to expand...
So the FDA probably needs a concrete illness before they can approve a drug to treat it.
 
Back in for 900 CGA @ $8.38 avg. Saw it drift down to 7 two days ago and feel stupid for not jumping on it. Missed a huge move up yesterday on large volume. It's finally busted thru $8 after consolidating the last few weeks, hopefully it can get thru the mid 8's then there's little resistence after that.

Bought a new name IFON - 2,000 shares at $1.68. I relearned a valuable lesson about low volume, low priced stocks, do not put a market order in! Price jumped 6 cents on my purchase alone, cost me $120. I've never seen my own purchase move the price of the stock, kind of neat.

Thinking I will probably get out of HEB today.

 
This might be bad for the market but I find it very encouraging.

Stocks slipped in early trading Friday after the Commerce Department reported that personal spending, incomes and savings all rose in May. What troubled investors, though, was that the savings rate soared to 6.9 percent, a 15-year high, while spending rose by a modest 0.3 percent.
Click to expand...
link
 
Dang it, was too busy farting around this morning with other stuff to get my sell for HEB in @ $2.48. Back down to the 2.20's now.

 
You must log in or register to reply here.

Similar threads

Stuart Ullman
Stock Speculation: WWE (Saudi Arabia), -22.59%
Replies
15
Views
1K
NotSmart
NotSmart
Rattle and Hum
Trading (investing) CBOE Stock Options
Replies
3
Views
475
Stuart Ullman
Stuart Ullman
The Z Machine
Personal Finance Question - Employee Stock Purchase
2
Replies
73
Views
3K
The Z Machine
The Z Machine

Users who are viewing this thread

Total: 1 (members: 0, guests: 1)
Back
Top